Alexion Pharmaceuticals Regional Account Manager, MD in Austria

Regional Account Manager

Metabolic Disorders East Austria

Location: Field-Based, Austria

Position Summary

The Regional Account Manager will develop commercial relationship with hospital and office based opinion leaders and decision makers in order to maximize access to Alexion products within key accounts/hospitals identified in the region.

Principal Responsibilities

  • Creates awareness of HPP and LAL disease and symptoms

  • Implements educational and disease awareness plans in accordance with written guidelines and processes, using approved educational resources and tools

  • Works closely with Medical Affairs team to ensure appropriate communication of medical and scientific information and response to requests for information from Healthcare Professionals in compliance with written guidelines and processes

  • Develops and maintains strong in-depth clinical, technical and scientific knowledge

  • Demonstrated ability to successfully identify key treatment centers, mapping of centers of expertise and medical experts in the area

  • Demonstrates the ability to educate on the diagnostic approach to the disease leading to a successful differential diagnosis and appropriate testing of patient populations

  • Appropriately utilizes all approved disease awareness educational tools and resources including power point presentations

  • Selling of Alexion products within legal boun­daries according to Alexion’s marketing and sales strategy

  • Provides a high level of disease awareness expertise timely and complete reporting to the senior position and continuous maintenance of the CRM database

  • Get insight from the customers about disease and other data relevant to understand the diseases in compliance with written guidelines

  • Develop network and professional relationship with local specialist including diagnostic specialists and laboratory centers

  • Effective administrator who efficiently manages time, educational tools and resources and workload

  • Effective verbal and written communication skills and organizational abilities

  • Collect and communicate pharmacovigilance information according to internal SOPs

  • Representation of Alexion Pharma Germany GmbH at regional, national and international events and congresses

Qualifications

  • Minimum 5 years Biotechnology/Pharmaceutical experience

  • Strong preference for one or more of following sales experience:

  • in the Endocrinology and Medical Genetics specialties and/or experience interacting to physicians specialized in treating bone disorders

  • with enzyme replacement therapy products

  • in the orphan or ultra-orphan area

  • Experience and background in the following areas is desirable:

  • in the Nephrology, Orthopedic surgery and Rheumatology specialties

  • Experience managing a self-injected product

  • Ability to work effectively independently and in an interdependent, team-oriented environment on a consistent basis

  • Experience in launching a biopharmaceutical in the past 3-5 years preferred

  • Ability to gain consistent access & develop strong, professional relationships for scientific exchange with healthcare providers in community and academic centers

  • Ability to travel within territory on a regular basis which will include frequent overnight and weekend travel

  • Valid driver’s license and clean driving

Education

  • Degree in life science and/or business/marketing

  • Advanced or Master’s degree ideal

Competencies

  • Works with an appropriate sense of urgency and drives for results / Ability to recognize business opportunities and act swiftly / Competent in business planning

  • A strong track record of perseverance and will-to-win with successful attainment of company goals despite challenges / Tenacious and solution focused

  • Places premium on being held accountable regardless of outcome / Sense of ethics and personal responsibility

  • A problem solver who demonstrates initiative, energy and enthusiasm; brings a positive, can-do approach to all challenges / Professional and mature approach with proactive and positive attitude

  • Excellent interpersonal skills with the ability to quickly assimilate into the team environment

  • Flexibility and ability to adapt to changing conditions

  • Networking and customer relationship development skills

  • Time management / prioritization skills

  • Ability to assimilate complex scientific information

  • Self-starter but also able to seek additional resources when required

  • Excellent communication skills

Compensation

  • Minimum Salary at 100% employment level would be EUR 35,000 gross p.a. We are willing to overpay according to market benchmarks and qualifications

As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. To learn more about Alexion, please visit www.alexionpharma.com or download our App for iPhones and Blackberries.

[[filter5]], [[filter1]]

[[filter4]]

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris® (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening ultra-rare disorders. As the global leader in complement inhibition, Alexion is strengthening and broadening its portfolio of complement inhibitors, including evaluating potential indications for eculizumab in additional severe and ultra-rare disorders. Alexion’s metabolic franchise includes two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare disorders, Strensiq® (asfotase alfa) to treat patients with hypophosphatasia (HPP) and Kanuma™ (sebelipase alfa) to treat patients with lysosomal acid lipase deficiency (LAL-D). In addition, Alexion is advancing the most robust rare disease pipeline in the biotech industry, with highly innovative product candidates in multiple therapeutic areas.